
Sonoma Pharmaceuticals, Inc.
SNOAHealthcare|Drug Manufacturers - Specialty & Generic|US
$1.11
+0.04 (+3.74%)
Tangible Book / Share
$1.71
Cash / Share
$1.39
Next Earnings Report
Nov 16, 2026
EPS est. -$0.10 · Revenue est. $5.3M
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jun 18, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (2)
Dec 2026
Est. completion
Dec 2040
Est. completion
Rheumatoid Arthritis (RA)
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
NCT07123038n=36
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.
SEC Filings (43)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 6, 2026 | 8-A12B/A | DocumentIndex | |
| Oct 6, 2026 | 8-K | Material event | DocumentIndex |
| Sep 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 19, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 23, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 9, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 24, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jun 18, 2026 | 8-K | Material event | DocumentIndex |
| Jun 18, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jun 16, 2026 | 10-K | Annual report | DocumentIndex |
| May 5, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 30, 2026 | 8-K | Material event | DocumentIndex |
| Apr 27, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Apr 27, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 23, 2026 | EFFECT | DocumentIndex | |
| Apr 23, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Apr 17, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Apr 9, 2026 | 8-K | Material event | DocumentIndex |
| Feb 10, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jan 28, 2026 | 8-K | Material event | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 2, 2026 | 8-K | Material event | DocumentIndex |
| Nov 4, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 23, 2025 | 8-K | Material event | DocumentIndex |
| Oct 9, 2025 | 8-K | Material event | DocumentIndex |
| Sep 29, 2025 | 8-K | Material event | DocumentIndex |
| Sep 26, 2025 | 8-K | Material event | DocumentIndex |
| Sep 26, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jul 11, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 17, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Jun 17, 2025 | 10-K | Annual report | DocumentIndex |
| Apr 28, 2025 | 8-K | Material event | DocumentIndex |
| Apr 7, 2025 | 8-K | Material event | DocumentIndex |
| Mar 25, 2025 | 8-K | Material event | DocumentIndex |
| Feb 5, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jan 30, 2025 | 8-K | Material event | DocumentIndex |